Evidence map›Paper›PMID 39313647›Full record

ArticleNature biotechnology2025

Chemical and topological design of multicapped mRNA and capped circular RNA to augment translation.

Hongyu Chen, Dangliang Liu, Abhishek Aditham, Jianting Guo, Jiahao Huang, Franklin Kostas, Kamal Maher, Mirco J Friedrich, Ramnik J Xavier, Feng Zhang and 1 more

Abstract read
In one paragraph

Article in Nature biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Towards mRNA therapeutics 2.0.Nature reviews. Drug discovery · 2026
    Review
  5. Circular Photocaged mRNA for Light-induced Late-stage Activation of Translation.Angewandte Chemie (International ed. in English) · 2026
    Article
  6. Cold-adapted RNA polymerase fromProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Review
  8. Article
  9. Cryo-EM reveals thatProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. IVT-free, chemically synthesized protein-encoding RNA oligonucleotides for rapid production of personalized cancer vaccines.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Article
  12. Acta pharmaceutica Sinica. B · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. "More" Artificial mRNAs: Beyond the Art of Nature.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hongyu Chen *Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-9496-8586
Dangliang Liu *Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-6598-8871
Abhishek Aditham *Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Jianting GuoDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-5691-5707
Jiahao HuangDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-6349-9799
Franklin KostasDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-0939-1154
Kamal MaherBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Mirco J FriedrichBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Ramnik J XavierBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Feng ZhangBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-0178-7995
Xiao WangDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA. xwangx@mit.edu.ORCID http://orcid.org/0000-0002-3090-9894

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Ramnik J Xavier · 1991 to 2026
$35.3M
Spatial and temporal resolution to dissect cellular circuits controlling intestinal physiology, immunity, and inflammatory pathologiesRC2DK135492 · NIDDK · BROAD INSTITUTE, INC. · PI Caroline Uhler, Ramnik J Xavier · 2023 to 2026
$7.9M
Programmable RNA-targeting toolsR01HG009761 · NHGRI · BROAD INSTITUTE, INC. · PI ZHANG, FENG · 2017 to 2024
$7.5M
Graduate Training in Computational and Systems BiologyT32GM087237 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BURGE, CHRISTOPHER B · 2009 to 2023
$4.6M
Single-cell in situ analysis of RNA modifications in intact tissuesDP2GM146245 · NIGMS · BROAD INSTITUTE, INC. · PI WANG, XIAO · 2021 to 2024
$2.4M
NHGRI NIH HHS R01 HG009761NIDDK NIH HHS P30 DK043351NIDDK NIH HHS RC2 DK135492NIGMS NIH HHS DP2 GM146245NIGMS NIH HHS T32 GM087237U.S. Department of Health & Human Services | National Institutes of Health (NIH) 1DP2GM146245U.S. Department of Health & Human Services | National Institutes of Health (NIH) 2R01HG009761-05U.S. Department of Health & Human Services | National Institutes of Health (NIH) DK135492U.S. Department of Health & Human Services | National Institutes of Health (NIH) DK43351
6 · The paper itself

Abstract

Protein and vaccine therapies based on mRNA would benefit from an increase in translation capacity. Here, we report a method to augment translation named ligation-enabled mRNA-oligonucleotide assembly (LEGO). We systematically screen different chemotopological motifs and find that a branched mRNA cap effectively initiates translation on linear or circular mRNAs without internal ribosome entry sites. Two types of chemical modification, locked nucleic acid (LNA) N

Indexed as

Protein BiosynthesisRNA CapsRNA, CircularRNA, MessengerAnimalsCOVID-19COVID-19 VaccinesHumansMiceOligonucleotidesSARS-CoV-2COVID-19 Vaccineslocked nucleic acidOligonucleotidesRNA CapsRNA, CircularRNA, Messenger

Identifiers

PMID39313647
PMCPMC11929619

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.